Stock Analysis
Avantor, Inc. (AVTR) Stock Analysis
Avantor, Inc. (AVTR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Avantor, Inc. (AVTR) currently has an AIQ Score of 55/100, indicating a neutral setup. Momentum is the strongest factor at 66/100. Quality is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
AVTR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $14.81 |
| AIQ Score | 55/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $9.6B |
| P/E Ratio (TTM) | 16.71 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.06 |
| Revenue (quarter ended 2026-06-30) | $1.69B |
| Dividend Yield (TTM) | 0.00% |
| Beta | 0.89 |
| Volume | 6.18M |
| 52-week range | $7.27-$15.93 |
| RSI 14 | 56.06 |
| 50-Day SMA | $13.00 |
| 200-Day SMA | $10.44 |
| Analyst Price Target | $10.60 |
| Next Earnings | Nov 4, 2026 |
AVTR
OverviewAVTR Stock Analysis Summary
Avantor, Inc. (AVTR) currently has an AIQ Score of 55/100, indicating a neutral setup. Momentum is the strongest factor at 66/100. Quality is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, AVTR has AIQ Score of 55/100 with Momentum base of 66/100 and fading Quality at 34/100. Wait for component alignment before adding exposure.
Momentum (66/100) leads while Quality (34/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.47% stock move · AVTR classified in Medical - Instruments & Supplies.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is AVTR Bullish or Bearish Right Now?
AVTR currently has a neutral overall setup. Momentum is the strongest factor at 66/100, while Quality is weakest at 34/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 66/100.
- - Risk Resilience is supportive at 60/100.
- - Price is +13.89% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (32 vs 6).
- - Analyst target implies -28.43% downside from the latest quote.
Current Consensus
AVTR's Technical Analysis Consensus is currently Strong Buy, with 32 buy, 7 neutral, and 6 sell votes. AVTR's 14-day RSI is 56.06, which places the stock in a constructive momentum range. AVTR's beta is 0.89, indicating market sensitivity broadly in line with the market.
What Changed in AVTR?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the AVTR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
AVTR Decision Framework
Public evidence layers, setup checks, and risk context for Avantor, Inc..
Avantor, Inc. (AVTR) Stock Analysis
Avantor, Inc. has an AIQ Score of 55/100 in a Neutral regime. Momentum is strongest at 66/100. Beta is 0.89, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | AVTR is in a Neutral AIQ regime with score 55/100. |
| Signal Conflict | The primary conflict is that momentum leads at 66/100 while quality lags at 34/100. |
| Factor Evidence | Momentum 66/100 · Value 64/100 · Quality 34/100 · Risk 60/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 66/100.
Momentum is 66/100 and RSI (14) is 56.1.
AVTR is in a Neutral regime at 55/100.
Risk factor is 60/100 with beta 0.89 and annual volatility 51.65%.
Current conflict: momentum leads at 66/100 while quality lags at 34/100.
AVTR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
AVTR Fundamentals
AVTR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
AVTR Technical Analysis
AVTR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
AVTR Stock Catalysts
Track AVTR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
AVTR Dividend Analysis
AVTR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
AVTR Financial Data
AVTR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
AVTR Risk Analysis
AVTR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
AVTR Stock News
AVTR stock news, market tone, recent headlines, and catalyst context.
AVTR vs Medical Devices Peers
Current peer cohort: AVTR · BAX · BDX · BSX · COO. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| AVTR Current stock | 55/100 | 64/100 | 66/100 | 60/100 | 0.5 | 51.65% | Current |
| BAX Baxter International | 42/100 | 69/100 | 30/100 | 54/100 | 0.11 | 43.45% | AVTR vs BAX |
| BDX Becton Dickinson | 48/100 | 63/100 | 37/100 | 47/100 | -0.16 | 30.60% | AVTR vs BDX |
| BSX Boston Scientific | 50/100 | 58/100 | 23/100 | 42/100 | -2.28 | 37.90% | AVTR vs BSX |
| COO Cooper Companies | 46/100 | 59/100 | 20/100 | 43/100 | -0.67 | 32.21% | AVTR vs COO |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 13, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching AVTR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for AVTR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
AVTR Stock FAQ
What is AVTR stock price today?
Avantor, Inc.'s current stock price is $14.81. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is AVTR bullish or bearish right now?
AVTR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is AVTR's market cap?
AVTR's market cap is $9.6B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is AVTR's current P/E ratio?
AVTR's current P/E ratio is 16.71 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is AVTR's RSI?
AVTR's 14-day RSI is 56.06 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is AVTR above its 50-day and 200-day moving averages?
AVTR is 13.89% from its 50-day SMA and 41.82% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is AVTR's next earnings date?
AVTR's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does AVTR pay a dividend?
AVTR's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.